Jeffrey Davidson joins Karmanos Cancer Institute Board of Directors

    NEXT STORY
    Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress
    PREV STORY
    Shire plc : 1st Quarter Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.

    NEWARK, Calif., March 29, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Pernix Therapeutics Appoints Two Board Members

    MORRISTOWN, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a ...

    author_avatar
    NASDAQ Market News

    Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404

    NEW YORK, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

    author_avatar
    NASDAQ Market News